{"protocolSection": {"identificationModule": {"nctId": "NCT03715998", "orgStudyIdInfo": {"id": "QGC001-2QG4"}, "organization": {"fullName": "Quantum Genomics SA", "class": "INDUSTRY"}, "briefTitle": "Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction", "officialTitle": "A Phase 2, Double-blind, Active-controlled, Dose-titrating Efficacy and Safety Study of Firibastat Compared to Ramipril Administered Orally, Twice Daily, Over 12 Weeks to Prevent Left Ventricular Dysfunction After Acute MI", "acronym": "QUORUM"}, "statusModule": {"statusVerifiedDate": "2020-12", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2019-06-04", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2021-07-08", "type": "ACTUAL"}, "completionDateStruct": {"date": "2021-07-08", "type": "ACTUAL"}, "studyFirstSubmitDate": "2018-10-19", "studyFirstSubmitQcDate": "2018-10-19", "studyFirstPostDateStruct": {"date": "2018-10-23", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2022-05-23", "resultsFirstSubmitQcDate": "2022-05-23", "resultsFirstPostDateStruct": {"date": "2023-02-27", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2022-05-23", "lastUpdatePostDateStruct": {"date": "2023-02-27", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Quantum Genomics SA", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "This is a multicenter, randomized, double-blind, active-controlled, dose-titrating phase 2 study to evaluate the safety and efficacy of firibastat administered orally BID (2 daily doses) versus ramipril administered orally BID over 12 weeks after acute anterior MI.\n\nSubjects will be followed for 12 weeks (over 4 study visits). A total of 294 male and female subjects with a diagnosis of first acute anterior MI will be randomized. The subjects will need to have a primary percutaneous coronary intervention (PCI) of the index MI related artery within 24 hours after MI.", "detailedDescription": "At Inclusion Visit (Visit 2 \\[within 72 hours after acute MI\\]), subjects will be randomly assigned to 1 of the following 3 treatment groups in a 1:1:1 ratio:\n\n* Group 1: Subjects will receive 50 mg firibastat BID for 2 weeks and then 100 mg BID for 10 weeks\n* Group 2: Subjects will receive 250 mg firibastat BID for 2 weeks and then 500 mg BID for 10 weeks\n* Group 3: Subjects will receive 2.5 mg ramipril BID for 2 weeks and then 5 mg BID for 10 weeks\n\nThen subjects will undergo study procedures at Titration Visit (Visit 3 \\[Day 14\\]), Treatment Visit (Visit 4 Day 42\\]) and End-of-Treatment Visit (Visit 5 \\[Day 84\\])."}, "conditionsModule": {"conditions": ["Myocardial Infarction"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 295, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Group 1: firibastat 100 mg", "type": "EXPERIMENTAL", "description": "Subjects will receive 50 mg firibastat BID for 2 weeks and then 100 mg BID for 10 weeks.", "interventionNames": ["Drug: Firibastat"]}, {"label": "Group 2: firibastat 500 mg", "type": "EXPERIMENTAL", "description": "Subjects will receive 250 mg firibastat BID for 2 weeks and then 500 mg BID for 10 weeks.", "interventionNames": ["Drug: Firibastat"]}, {"label": "Group 3: ramipril 5 mg", "type": "ACTIVE_COMPARATOR", "description": "Subjects will receive 2.5 mg ramipril BID for 2 weeks and then 5 mg BID for 10 weeks.", "interventionNames": ["Drug: Ramipril"]}], "interventions": [{"type": "DRUG", "name": "Ramipril", "description": "1 or 2 capsules administered orally, twice daily", "armGroupLabels": ["Group 3: ramipril 5 mg"]}, {"type": "DRUG", "name": "Firibastat", "description": "1 or 2 capsules administered orally, twice daily", "armGroupLabels": ["Group 1: firibastat 100 mg", "Group 2: firibastat 500 mg"], "otherNames": ["QGC001"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Left Ventricular Ejection Fraction Assessed by Cardiac Magnetic Resonance Imaging (CMRI)", "description": "Comparison of the effects of BID oral administration of 2 doses of firibastat to those of BID oral administration of ramipril on the change from Baseline in LVEF on Day 84", "timeFrame": "84 days"}], "secondaryOutcomes": [{"measure": "Left-ventricle End-diastolic Volume Assessed by CMRI", "description": "Comparison of the effects of BID administration of firibastat and ramipril on the change from Baseline to Day 84 in left-ventricle end-diastolic volume", "timeFrame": "84 days"}, {"measure": "Left-ventricle End-systolic Volume Assessed by CMRI", "description": "Comparison of the effects of BID administration of firibastat and ramipril on the change from Baseline to Day 84 in left-ventricle end-systolic volume", "timeFrame": "84 days"}, {"measure": "Major Cardiac Event (MACE): Combined Clinical Endpoint of Cardiovascular Death, MI, and Cardiac Hospitalization", "description": "Comparison of the effects of BID administration of firibastat and ramipril on major cardiac event (MACE) over 84 days", "timeFrame": "84 days"}, {"measure": "N-terminal Pro B-type Natriuretic Peptide (NT proBNP)", "description": "Comparison of the effects of BID administration of firibastat and ramipril on the change from Baseline to Day 84 in N-terminal pro b-type natriuretic peptide (NT proBNP)", "timeFrame": "84 days"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of first acute anterior MI (ST-elevation myocardial infarction) defined as chest pain \\>30 minutes and ST elevation \u22650.2 mV in at least 2 consecutive electrocardiogram (ECG) leads in the anterior area (DI, aVL, V1 V6).\n* Primary PCI of the index-MI-related artery within 24 hours after the MI.\n\nExclusion Criteria:\n\n* Body mass index \\>45 kg/m\u00b2.\n* Subject is hemodynamically unstable or has cardiogenic shock.\n* Subjects with clinical signs of HF (Kilipp III and IV).\n* Systolic blood pressure \\<100 mmHg at inclusion visit\n* Early primary PCI of the index-MI-related artery performed within 3 hours after MI.\n* Subjects treated with angiotensin-converting-enzyme inhibitor (ACE I), angiotensin receptor blocker (ARB) or sacubitril/valsartan prior to the index magnetic resonance imaging. Note: if treatment was for HTN, ACE I/ARB should be stopped, and, if necessary, another therapeutic class can be prescribed for HTN. If the ACE I/ARB was prescribed for congestive HF, the subject is not considered eligible; if the ACE I/ARB prescribed for another reason cannot be stopped, the subject is not eligible for study inclusion.\n* Subjects scheduled for implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy, or pacemaker within the next 3 months. If an ICD is indicated for ventricular arrhythmia during the course of the study, a life vest, when possible, should be prescribed and the ICD scheduled after study completion.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Gilles Montalescot, MD, PhD", "affiliation": "Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re - Paris", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Groupe Hospitalier Pitie-Salp\u00eatri\u00e8re - Institut de Cardiologie", "city": "Paris", "zip": "75013", "country": "France", "geoPoint": {"lat": 48.85341, "lon": 2.3488}}, {"facility": "UKSH Kiel", "city": "Kiel", "country": "Germany", "geoPoint": {"lat": 54.32133, "lon": 10.13489}}, {"facility": "Central Hospital of Hungarian Army", "city": "Budapest", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Krakowski Szpital Specjalistyczny im. Jana Paw\u0142a II", "city": "Krak\u00f3w", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "NUSCH Bratislava Dpt. of Acute Cardiology", "city": "Bratislava", "country": "Slovakia", "geoPoint": {"lat": 48.14816, "lon": 17.10674}}, {"facility": "Hospital La Paz,", "city": "Madrid", "country": "Spain", "geoPoint": {"lat": 40.4165, "lon": -3.70256}}, {"facility": "Freeman Hospital Newcastle upon Tyne", "city": "Newcastle", "country": "United Kingdom", "geoPoint": {"lat": 54.97328, "lon": -1.61396}}]}, "referencesModule": {"references": [{"pmid": "33027067", "type": "DERIVED", "citation": "Khosla J, Aronow WS, Frishman WH. Firibastat: An Oral First-in-Class Brain Aminopeptidase A Inhibitor for Systemic Hypertension. Cardiol Rev. 2022 Jan-Feb 01;30(1):50-55. doi: 10.1097/CRD.0000000000000360."}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Group 1: Firibastat 100 mg", "description": "Subjects will receive 50 mg firibastat BID for 2 weeks and then 100 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "FG001", "title": "Group 2: Firibastat 500 mg", "description": "Subjects will receive 250 mg firibastat BID for 2 weeks and then 500 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "FG002", "title": "Group 3: Ramipril 2.5 mg", "description": "Subjects will receive 5 mg ramipril BID for 2 weeks and then 5 mg BID for 10 weeks.\n\nRamipril: 1 or 2 capsules administered orally, twice daily"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "98"}, {"groupId": "FG001", "numSubjects": "99"}, {"groupId": "FG002", "numSubjects": "98"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "81"}, {"groupId": "FG001", "numSubjects": "80"}, {"groupId": "FG002", "numSubjects": "88"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "17"}, {"groupId": "FG001", "numSubjects": "19"}, {"groupId": "FG002", "numSubjects": "10"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Group 1: Firibastat 100 mg", "description": "Subjects will receive 50 mg firibastat BID for 2 weeks and then 100 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "BG001", "title": "Group 2: Firibastat 500 mg", "description": "Subjects will receive 250 mg firibastat BID for 2 weeks and then 500 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "BG002", "title": "Group 3: Ramipril 5 mg", "description": "Subjects will receive 2.5 mg ramipril BID for 2 weeks and then 5 mg BID for 10 weeks.\n\nRamipril: 1 or 2 capsules administered orally, twice daily"}, {"id": "BG003", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "98"}, {"groupId": "BG001", "value": "99"}, {"groupId": "BG002", "value": "98"}, {"groupId": "BG003", "value": "295"}]}], "measures": [{"title": "Age, Categorical", "populationDescription": "Age analyzed on mITT population.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "72"}, {"groupId": "BG001", "value": "77"}, {"groupId": "BG002", "value": "80"}, {"groupId": "BG003", "value": "229"}]}], "categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "57"}, {"groupId": "BG001", "value": "57"}, {"groupId": "BG002", "value": "62"}, {"groupId": "BG003", "value": "176"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "15"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "18"}, {"groupId": "BG003", "value": "53"}]}]}]}, {"title": "Sex: Female, Male", "populationDescription": "Gender analyzed on mITT population", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "72"}, {"groupId": "BG001", "value": "77"}, {"groupId": "BG002", "value": "80"}, {"groupId": "BG003", "value": "229"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "17"}, {"groupId": "BG001", "value": "18"}, {"groupId": "BG002", "value": "20"}, {"groupId": "BG003", "value": "55"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "55"}, {"groupId": "BG001", "value": "59"}, {"groupId": "BG002", "value": "60"}, {"groupId": "BG003", "value": "174"}]}]}]}, {"title": "Race and Ethnicity Not Collected", "populationDescription": "Race and Ethnicity were not collected from any participant.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}], "categories": [{"measurements": [{"groupId": "BG003", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Hungary", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "98"}, {"groupId": "BG001", "value": "99"}, {"groupId": "BG002", "value": "98"}, {"groupId": "BG003", "value": "295"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "25"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "22"}, {"groupId": "BG003", "value": "67"}]}]}, {"title": "Poland", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "98"}, {"groupId": "BG001", "value": "99"}, {"groupId": "BG002", "value": "98"}, {"groupId": "BG003", "value": "295"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "26"}, {"groupId": "BG001", "value": "25"}, {"groupId": "BG002", "value": "23"}, {"groupId": "BG003", "value": "74"}]}]}, {"title": "United Kingdom", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "98"}, {"groupId": "BG001", "value": "99"}, {"groupId": "BG002", "value": "98"}, {"groupId": "BG003", "value": "295"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "2"}, {"groupId": "BG003", "value": "5"}]}]}, {"title": "Slovakia", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "98"}, {"groupId": "BG001", "value": "99"}, {"groupId": "BG002", "value": "98"}, {"groupId": "BG003", "value": "295"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "21"}, {"groupId": "BG001", "value": "26"}, {"groupId": "BG002", "value": "23"}, {"groupId": "BG003", "value": "70"}]}]}, {"title": "France", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "98"}, {"groupId": "BG001", "value": "99"}, {"groupId": "BG002", "value": "98"}, {"groupId": "BG003", "value": "295"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "13"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "13"}, {"groupId": "BG003", "value": "40"}]}]}, {"title": "Germany", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "98"}, {"groupId": "BG001", "value": "99"}, {"groupId": "BG002", "value": "98"}, {"groupId": "BG003", "value": "295"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "4"}, {"groupId": "BG003", "value": "11"}]}]}, {"title": "Spain", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "98"}, {"groupId": "BG001", "value": "99"}, {"groupId": "BG002", "value": "98"}, {"groupId": "BG003", "value": "295"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "8"}, {"groupId": "BG001", "value": "9"}, {"groupId": "BG002", "value": "11"}, {"groupId": "BG003", "value": "28"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Left Ventricular Ejection Fraction Assessed by Cardiac Magnetic Resonance Imaging (CMRI)", "description": "Comparison of the effects of BID oral administration of 2 doses of firibastat to those of BID oral administration of ramipril on the change from Baseline in LVEF on Day 84", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage of left ventricular volumes", "timeFrame": "84 days", "groups": [{"id": "OG000", "title": "Group 1: Firibastat 100 mg", "description": "Subjects will receive 50 mg firibastat BID for 2 weeks and then 100 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "OG001", "title": "Group 2: Firibastat 500 mg", "description": "Subjects will receive 250 mg firibastat BID for 2 weeks and then 500 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "OG002", "title": "Group 3: Ramipril 5 mg", "description": "Subjects will receive 2.5 mg ramipril BID for 2 weeks and then 5 mg BID for 10 weeks.\n\nRamipril: 1 or 2 capsules administered orally, twice daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "72"}, {"groupId": "OG001", "value": "77"}, {"groupId": "OG002", "value": "80"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.6", "spread": "1.2"}, {"groupId": "OG001", "value": "5.3", "spread": "1.1"}, {"groupId": "OG002", "value": "5.7", "spread": "1.1"}]}]}]}, {"type": "SECONDARY", "title": "Left-ventricle End-diastolic Volume Assessed by CMRI", "description": "Comparison of the effects of BID administration of firibastat and ramipril on the change from Baseline to Day 84 in left-ventricle end-diastolic volume", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "84 days", "groups": [{"id": "OG000", "title": "Group 1: Firibastat 100 mg", "description": "Subjects will receive 50 mg firibastat BID for 2 weeks and then 100 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "OG001", "title": "Group 2: Firibastat 500 mg", "description": "Subjects will receive 250 mg firibastat BID for 2 weeks and then 500 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "OG002", "title": "Group 3: Ramipril 5 mg", "description": "Subjects will receive 2.5 mg ramipril BID for 2 weeks and then 5 mg BID for 10 weeks.\n\nRamipril: 1 or 2 capsules administered orally, twice daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "72"}, {"groupId": "OG001", "value": "77"}, {"groupId": "OG002", "value": "80"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "14.2", "spread": "4.5"}, {"groupId": "OG001", "value": "12.7", "spread": "4.3"}, {"groupId": "OG002", "value": "9.4", "spread": "4.4"}]}]}]}, {"type": "SECONDARY", "title": "Left-ventricle End-systolic Volume Assessed by CMRI", "description": "Comparison of the effects of BID administration of firibastat and ramipril on the change from Baseline to Day 84 in left-ventricle end-systolic volume", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "84 days", "groups": [{"id": "OG000", "title": "Group 1: Firibastat 100 mg", "description": "Subjects will receive 50 mg firibastat BID for 2 weeks and then 100 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "OG001", "title": "Group 2: Firibastat 500 mg", "description": "Subjects will receive 250 mg firibastat BID for 2 weeks and then 500 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "OG002", "title": "Group 3: Ramipril 5 mg", "description": "Subjects will receive 2.5 mg ramipril BID for 2 weeks and then 5 mg BID for 10 weeks.\n\nRamipril: 1 or 2 capsules administered orally, twice daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "72"}, {"groupId": "OG001", "value": "77"}, {"groupId": "OG002", "value": "80"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.5", "spread": "3.3"}, {"groupId": "OG001", "value": "-0.4", "spread": "3.2"}, {"groupId": "OG002", "value": "-3.1", "spread": "3.2"}]}]}]}, {"type": "SECONDARY", "title": "Major Cardiac Event (MACE): Combined Clinical Endpoint of Cardiovascular Death, MI, and Cardiac Hospitalization", "description": "Comparison of the effects of BID administration of firibastat and ramipril on major cardiac event (MACE) over 84 days", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Event", "timeFrame": "84 days", "groups": [{"id": "OG000", "title": "Group 1: Firibastat 100 mg", "description": "Subjects will receive 50 mg firibastat BID for 2 weeks and then 100 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "OG001", "title": "Group 2: Firibastat 500 mg", "description": "Subjects will receive 250 mg firibastat BID for 2 weeks and then 500 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "OG002", "title": "Group 3: Ramipril 5 mg", "description": "Subjects will receive 2.5 mg ramipril BID for 2 weeks and then 5 mg BID for 10 weeks.\n\nRamipril: 1 or 2 capsules administered orally, twice daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "98"}, {"groupId": "OG001", "value": "98"}, {"groupId": "OG002", "value": "98"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "8"}, {"groupId": "OG002", "value": "6"}]}]}]}, {"type": "SECONDARY", "title": "N-terminal Pro B-type Natriuretic Peptide (NT proBNP)", "description": "Comparison of the effects of BID administration of firibastat and ramipril on the change from Baseline to Day 84 in N-terminal pro b-type natriuretic peptide (NT proBNP)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/ml", "timeFrame": "84 days", "groups": [{"id": "OG000", "title": "Group 1: Firibastat 100 mg", "description": "Subjects will receive 50 mg firibastat BID for 2 weeks and then 100 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "OG001", "title": "Group 2: Firibastat 500 mg", "description": "Subjects will receive 250 mg firibastat BID for 2 weeks and then 500 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily"}, {"id": "OG002", "title": "Group 3: Ramipril 5 mg", "description": "Subjects will receive 2.5 mg ramipril BID for 2 weeks and then 5 mg BID for 10 weeks.\n\nRamipril: 1 or 2 capsules administered orally, twice daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "72"}, {"groupId": "OG001", "value": "77"}, {"groupId": "OG002", "value": "80"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-1618.7", "spread": "1381.7"}, {"groupId": "OG001", "value": "-1596.4", "spread": "2279.6"}, {"groupId": "OG002", "value": "-1735.6", "spread": "2326.5"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "2", "timeFrame": "Adverse events collected from the ICF signature to the end of the study.", "eventGroups": [{"id": "EG000", "title": "Group 1: Firibastat 100 mg", "description": "Subjects will receive 50 mg firibastat BID for 2 weeks and then 100 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily", "deathsNumAffected": 2, "deathsNumAtRisk": 98, "seriousNumAffected": 11, "seriousNumAtRisk": 98, "otherNumAffected": 43, "otherNumAtRisk": 98}, {"id": "EG001", "title": "Group 2: Firibastat 500 mg", "description": "Subjects will receive 250 mg firibastat BID for 2 weeks and then 500 mg BID for 10 weeks.\n\nFiribastat: 1 or 2 capsules administered orally, twice daily", "deathsNumAffected": 1, "deathsNumAtRisk": 98, "seriousNumAffected": 18, "seriousNumAtRisk": 98, "otherNumAffected": 54, "otherNumAtRisk": 98}, {"id": "EG002", "title": "Group 3: Ramipril 5 mg", "description": "Subjects will receive 2.5 mg ramipril BID for 2 weeks and then 5 mg BID for 10 weeks.\n\nRamipril: 1 or 2 capsules administered orally, twice daily", "deathsNumAffected": 1, "deathsNumAtRisk": 98, "seriousNumAffected": 10, "seriousNumAtRisk": 98, "otherNumAffected": 54, "otherNumAtRisk": 98}], "seriousEvents": [{"term": "Anemia", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}]}, {"term": "Myocardial Infarction", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}]}, {"term": "Angina pectoris", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Aortic valve incompetence", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Cardiac Arrest", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Cardiac tamponade", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Coronary artery disease", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Dressler's syndrome", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Pericardial effusion", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}]}, {"term": "Pericarditis", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Ventricule rupture", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Hyperplasia adrenal", "organSystem": "Endocrine disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Retinal Detachment", "organSystem": "Eye disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Chest pain or chest discomfort (non cardiac)", "organSystem": "General disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 98}]}, {"term": "Death", "organSystem": "General disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Vascular stent trombosis", "organSystem": "General disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}]}, {"term": "COVID19", "organSystem": "Infections and infestations", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Staphylococcal Bacteraemia", "organSystem": "Infections and infestations", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}]}, {"term": "Limb injury", "organSystem": "Injury, poisoning and procedural complications", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Periprocedural myocadial infarction", "organSystem": "Injury, poisoning and procedural complications", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Electrocardiogram QT prolonged", "organSystem": "Investigations", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Spinal pain", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Cerebrovascular accident", "organSystem": "Nervous system disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Ischaemic stroke", "organSystem": "Nervous system disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Acute kidney injury", "organSystem": "Renal and urinary disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}]}, {"term": "Dry throat", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}]}, {"term": "Dypsnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}]}, {"term": "Pulmonary oedema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Drug eruption", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Rash maculo-papular", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}]}, {"term": "Aortic Aneurysm", "organSystem": "Vascular disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Hypertensive crisis", "organSystem": "Vascular disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}], "otherEvents": [{"term": "Bradycardia", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 4, "numAffected": 3, "numAtRisk": 98}]}, {"term": "Coronary artery disease", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 4, "numAffected": 4, "numAtRisk": 98}]}, {"term": "Dressler's syndrome", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Pericardial effusion", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}]}, {"term": "Dermatitis Allergic", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Drug eruption", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Ecchymosis", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Pruritus", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Rash", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 9, "numAffected": 8, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 98}]}, {"term": "rash maculo-papular", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}]}, {"term": "Skin exfoliation", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "COVID-19", "organSystem": "Infections and infestations", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 6, "numAffected": 6, "numAtRisk": 98}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Hypotension", "organSystem": "Vascular disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}]}, {"term": "Orthostatic hypotension", "organSystem": "Vascular disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Chest disconfort", "organSystem": "General disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 5, "numAffected": 5, "numAtRisk": 98}]}, {"term": "Chest pain", "organSystem": "General disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 6, "numAffected": 5, "numAtRisk": 98}]}, {"term": "Peripheral swelling", "organSystem": "General disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Pyrexia", "organSystem": "General disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}]}, {"term": "Myalgia", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}]}, {"term": "Spinal Pain", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Diarrhea", "organSystem": "Gastrointestinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 6, "numAffected": 5, "numAtRisk": 98}]}, {"term": "Lip swelling", "organSystem": "Gastrointestinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}]}, {"term": "Nausea", "organSystem": "Gastrointestinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}]}, {"term": "Dypsnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 3, "numAffected": 2, "numAtRisk": 98}]}, {"term": "Epistaxis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}]}, {"term": "Hyperkalemia", "organSystem": "Metabolism and nutrition disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 98}]}, {"term": "Liver disorder", "organSystem": "Hepatobiliary disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 4, "numAffected": 3, "numAtRisk": 98}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 4, "numAffected": 4, "numAtRisk": 98}]}, {"term": "ECG QT prolonged", "organSystem": "Investigations", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "GT60", "restrictiveAgreement": true}, "pointOfContact": {"title": "Dr Bruno Besse", "organization": "Quantum Genomics", "email": "bruno.besse@quantum-genomics.com", "phone": "+33 1 85 34 77 73"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2019-10-10", "uploadDate": "2022-05-19T09:59", "filename": "Prot_000.pdf", "size": 1144008}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2021-07-20", "uploadDate": "2022-05-20T10:44", "filename": "SAP_001.pdf", "size": 441841}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-07-01"}, "conditionBrowseModule": {"meshes": [{"id": "D000009203", "term": "Myocardial Infarction"}, {"id": "D000018754", "term": "Ventricular Dysfunction"}, {"id": "D000018487", "term": "Ventricular Dysfunction, Left"}, {"id": "D000007238", "term": "Infarction"}], "ancestors": [{"id": "D000007511", "term": "Ischemia"}, {"id": "D000010335", "term": "Pathologic Processes"}, {"id": "D000009336", "term": "Necrosis"}, {"id": "D000017202", "term": "Myocardial Ischemia"}, {"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000014652", "term": "Vascular Diseases"}], "browseLeaves": [{"id": "M12155", "name": "Myocardial Infarction", "asFound": "Myocardial Infarction", "relevance": "HIGH"}, {"id": "M10282", "name": "Infarction", "asFound": "Infarction", "relevance": "HIGH"}, {"id": "M20824", "name": "Ventricular Dysfunction", "asFound": "Ventricular Dysfunction", "relevance": "HIGH"}, {"id": "M20591", "name": "Ventricular Dysfunction, Left", "asFound": "Left Ventricular Dysfunction", "relevance": "HIGH"}, {"id": "M10543", "name": "Ischemia", "relevance": "LOW"}, {"id": "M12284", "name": "Necrosis", "relevance": "LOW"}, {"id": "M6546", "name": "Coronary Artery Disease", "relevance": "LOW"}, {"id": "M19506", "name": "Myocardial Ischemia", "relevance": "LOW"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M17400", "name": "Vascular Diseases", "relevance": "LOW"}, {"id": "T170", "name": "Acute Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000017257", "term": "Ramipril"}, {"id": "C000528573", "term": "Firibastat"}], "ancestors": [{"id": "D000000806", "term": "Angiotensin-Converting Enzyme Inhibitors"}, {"id": "D000011480", "term": "Protease Inhibitors"}, {"id": "D000004791", "term": "Enzyme Inhibitors"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000000959", "term": "Antihypertensive Agents"}], "browseLeaves": [{"id": "M19553", "name": "Ramipril", "asFound": "Mandibular", "relevance": "HIGH"}, {"id": "M189443", "name": "Firibastat", "asFound": "Indwelling urinary catheter", "relevance": "HIGH"}, {"id": "M7951", "name": "Enzyme Inhibitors", "relevance": "LOW"}, {"id": "M4134", "name": "Angiotensin-Converting Enzyme Inhibitors", "relevance": "LOW"}, {"id": "M19609", "name": "HIV Protease Inhibitors", "relevance": "LOW"}, {"id": "M14343", "name": "Protease Inhibitors", "relevance": "LOW"}, {"id": "M4277", "name": "Antihypertensive Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AnAg", "name": "Antihypertensive Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Infe", "name": "Anti-Infective Agents"}]}}, "hasResults": true}